Photo by nci from unsplash
Sign Up to like & get
recommendations!
1
Published in 2021 at "FEBS Letters"
DOI: 10.1002/1873-3468.14169
Abstract: Sialic acid‐binding immunoglobulin‐like lectin‐15 (Siglec‐15) has been identified as a novel potential target for cancer immunotherapy. Here, we explored the role of Siglec‐15 in human hepatoma cells. In this study, we found that the expression…
read more here.
Keywords:
siglec;
hepatoma cells;
promotes migration;
cd44 ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "Cellular and Molecular Life Sciences"
DOI: 10.1007/s00018-020-03601-z
Abstract: Polysialic acid (polySia) emerges as a novel regulator of microglia activity. We recently identified polysialylated proteins in the Golgi compartment of murine microglia that are released in response to inflammatory stimulation. Since exogenously added polySia…
read more here.
Keywords:
siglec;
polysialic acid;
response;
polysia ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "iScience"
DOI: 10.1016/j.isci.2020.101231
Abstract: Summary Siglec-10 is an inhibitory I-type lectin selectively recognizing sialoglycans exposed on cell surfaces, involved in several patho-physiological processes. The key role Siglec-10 plays in the regulation of immune cell functions has made it a…
read more here.
Keywords:
siglec;
human siglec;
sialoglycans human;
recognition sialoglycans ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "Medical Hypotheses"
DOI: 10.1016/j.mehy.2020.110168
Abstract: Abstract SARS-CoV-2 interaction with the ACE-2 receptor cannot alone explain the demography and remarkable variation in clinical progression of Covid-19 infection. Unlike SARS-CoV, the cause of SARS, several SARS-CoV-2 spike glycans contain sialic acid residues.…
read more here.
Keywords:
siglec;
cd33;
severe covid;
sars cov ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Molecular pharmaceutics"
DOI: 10.1021/acs.molpharmaceut.2c00557
Abstract: Tumor-associated macrophages (TAMs) possess great potential in the development of ovarian cancer (OC). Aberrant GATA-binding protein-3 (GATA3) expression has been found in TAM-derived extracellular vesicles (EVs). This study is intended to investigate the regulatory mechanism…
read more here.
Keywords:
cd24 siglec;
gata3;
immune escape;
resistance ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2019 at "Journal of the American Chemical Society"
DOI: 10.1021/jacs.9b05769
Abstract: The Siglec family of sialic acid binding im-munoglobulin-like cell surface receptors have emerged as attractive targets for cell directed therapies due to their restricted expression on immune cells, endocytic properties and ability to modulate receptor…
read more here.
Keywords:
siglec;
sialoside analog;
sulfonamide sialoside;
targeting siglec ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
0
Published in 2021 at "Leukemia"
DOI: 10.1038/s41375-021-01188-3
Abstract: The only current curative treatment for chronic lymphocytic leukemia (CLL) is allogenic hematopoietic stem cell transplantation. Chimeric antigen receptor treatment targeting CD19 for CLL achieved some complete responses, suggesting the need for alternative or combinational…
read more here.
Keywords:
siglec;
cll;
treatment;
antigen ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2017 at "Scientific Reports"
DOI: 10.1038/s41598-017-09120-5
Abstract: Chronic obstructive pulmonary disease (COPD) is a common inflammatory lung disease. Sialic acid-binding immunoglobulin-type lectins 9 (Siglec-9) is predominantly expressed on innate immune cells and has been shown to exert regulatory effect on immune cells…
read more here.
Keywords:
siglec;
chronic obstructive;
obstructive pulmonary;
disease ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
0
Published in 2023 at "Journal of Immunotherapy (Hagerstown, Md. : 1997)"
DOI: 10.1097/cji.0000000000000465
Abstract: Siglec-15, an inhibitory immune checkpoint, is an emerging target in cancer immunotherapy. Blocking the function of Siglec-15 is an excellent strategy for cancer treatment and antibody blockade has been used to target Siglec-15. However, whether…
read more here.
Keywords:
enhancing anti;
potency;
mediated effector;
effector functions ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Cancer Science"
DOI: 10.1111/cas.15631
Abstract: Although effective, immune checkpoint blockade induces response in only a subset of cancer patients. There is an urgent need to discover new immune checkpoint targets. Recently, it was found that a class of sialic acid–binding…
read more here.
Keywords:
function;
igg epithelial;
sialylated igg;
sia igg ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2021 at "Microbiology Spectrum"
DOI: 10.1128/spectrum.00399-21
Abstract: Escherichia coli K1 is a leading cause of neonatal meningitis. The mortality and morbidity of this disease remain significantly high despite antibiotic therapy. ABSTRACT Escherichia coli K1 causes bacteremia and meningitis in human neonates. The…
read more here.
Keywords:
parent strain;
siglec;
escherichia coli;
psa ... See more keywords